0.2246
전일 마감가:
$0.213
열려 있는:
$0.2178
하루 거래량:
3.31M
Relative Volume:
0.20
시가총액:
$2.67M
수익:
-
순이익/손실:
$-11.53M
주가수익비율:
-0.0466
EPS:
-4.82
순현금흐름:
$-11.12M
1주 성능:
+4.81%
1개월 성능:
-29.83%
6개월 성능:
-69.11%
1년 성능:
-86.22%
프로세사 파마슈티컬스 Stock (PCSA) Company Profile
명칭
Processa Pharmaceuticals Inc
전화
443-776-3133
주소
7380 COCA COLA DRIVE, HANOVER
PCSA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PCSA
Processa Pharmaceuticals Inc
|
0.2246 | 5.61M | 0 | -11.53M | -11.12M | -4.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-25 | 개시 | H.C. Wainwright | Buy |
프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스
What drives Processa Pharmaceuticals Inc. stock priceRapid wealth accumulation - Autocar Professional
What analysts say about Processa Pharmaceuticals Inc. stockRapid growth trajectories - Autocar Professional
Processa Pharmaceuticals Inc. Stock Analysis and ForecastRapid profit acceleration - jammulinksnews.com
Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional
RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register
Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - TipRanks
The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest
How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser
Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com
What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Best Performing Stock Suggestions - Newser
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest
Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest
Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest
12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey
HC Wainwright Has Positive Estimate for Heatwurx Q2 Earnings - Defense World
Processa terminates license agreement for PCS3117 - TipRanks
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com
Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest
Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media
Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks
Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - The Manila Times
Processa Pharmaceuticals (PCSA) Sets Public Offering Price at $0 - GuruFocus
Processa Pharmaceuticals Signs Binding Term Sheet Granting - GlobeNewswire
Processa Pharmaceuticals (PCSA) Enters Licensing Agreement for G - GuruFocus
Processa Pharmaceuticals Prices of $7 Million Public Offering - citybiz
Processa inks licensing deal with Intact for gastroparesis drug - Investing.com
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering | PCSA Stock News - GuruFocus
Processa Pharmaceuticals (PCSA) Announces Public Offering Pricin - GuruFocus
Processa Pharmaceuticals Prices $7 Million Public Offering - MarketScreener
Processa Pares Gains on Equity Offer News - MarketWatch
Processa Pharmaceuticals (PCSA) Announces Public Offering Pricing | PCSA Stock News - GuruFocus
프로세사 파마슈티컬스 (PCSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):